semaglutide and appendix (commonly known as Ozempic® or Wegovy®) is administered through a simple subcutaneous injection, allowing the medication to be absorbed beneath the skin into fat cells for steady, effective results. Once Ozempic (Semaglutide): Weight-Loss Mechanism, Side

Injectable semaglutide dosage Ozempic dosing begins at 0.25 mg once weekly for the first month to help your body adjust, then increases to 0.5 mg weekly for at least four weeks

Weight-loss results are self-reported, not typical, and vary based on starting weight, adherence, and individual health

Patients may discuss: Medication access Insurance coverage Self-pay options Side effects and treatment expectations Long-term weight management goals Serving Patients Across New York Queens Brooklyn Bronx Manhattan Staten Island Long Island Buffalo Rochester Albany Syracuse Yonkers White Plains New Rochelle Hempstead Insurance Verification & Self-Pay Options GoalBMI Wellness helps eligible patients understand available treatment pathways before starting semaglutide therapy

For patients whose primary goal is visceral fat reduction, we use Tesamorelin, which is FDA-approved for that specific indication and has stronger clinical data for fat metabolism than sermorelin